Crystal Bioscience, Inc. has applied to register the trademark OMNITIDES with the US Patent and Trademark Office for biological reagents for medical use and diagnostic preparations for medical purposes (Class 5: pharmaceuticals and supplements), and for goods or services in 3 other classes. The filing basis is an intent to use the mark in commerce (USPTO record, serial 50146214, October 6, 2026).
Is this your company?
Free check on Crystal Bioscience, Inc.: what is on record about the company behind this mark →
Crystal Bioscience, Inc., a corporation organized in California, applied to register the trademark OMNITIDES with the United States Patent and Trademark Office on 2026-10-06, serial number 50146214. The application covers 4 classes of goods and services, Class 1 (Chemicals); Class 5 (Pharmaceuticals and supplements); Class 40 (Material treatment); Class 42 (Software as a service and technology services), and is based on an intent to use the mark in commerce (the goods or services are not yet sold under it). The latest step on the record is "Application filing receipt mailed" on 2026-10-06.
| Mark | OMNITIDES |
|---|---|
| Applicant | Crystal Bioscience, Inc., a corporation organized in California |
| Applicant's location | Emeryville, California |
| Serial number | 50146214 |
| Filed | 2026-10-06 |
| Filing basis | An intent to use the mark in commerce (the goods or services are not yet sold under it) |
| Classes | Class 1 (Chemicals); Class 5 (Pharmaceuticals and supplements); Class 40 (Material treatment); Class 42 (Software as a service and technology services) |
| Latest step on the record | Application filing receipt mailed, 2026-10-06 |
| Mark description | The mark consists of the word OMNITIDES in a stylized font with a structured peptide ribbon over thesecond letter "i". |
Want the whole picture on Crystal Bioscience, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Crystal Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Crystal Bioscience, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What will OMNITIDES be used for?
Class 1 (Chemicals)
synthesized peptides for scientific and research use; for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research, product development, and manufacture of pharmaceuticals; chemical reagents for use in evaluating genetic material, namely, the detection, measurement and identification of genetic materials and their compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use; synthesized peptides for scientific and research use, the amino acid sequences of which were identified through or derived from naturally optimized, in vivo generated biological processes; synthesized peptides for scientific and research use, based on peptide sequences originally generated and optimized in vivo
Class 5 (Pharmaceuticals and supplements)
synthesized peptides for medical use, namely, for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; biological reagents for medical use; chemical reagents for medical use, namely, for the detection, measurement and identification of genetic materials; biological tissue cultures, namely, animal tissue cultures for medical purposes; radiopharmaceutical compositions for medical diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides for use in drug discovery of pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; chemical preparations for use in drug discovery for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; pharmaceutical preparations for use in the treatment of medical conditions, namely, suppressing tumors; diagnostic preparations for medical purposes; pharmaceutical preparations in the nature of synthesized peptides for use in drug discovery and pharmaceuticals for the treatment of medical purposes; synthesized proteins and chemical preparations for use in drug discovery and pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain
Class 40 (Material treatment)
manufacture of synthetic peptides to the order and specification of others; peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; discovery-to-synthesis of synthetic peptides
Class 42 (Software as a service and technology services)
scientific research services in the field of the analysis and synthesis of peptides; scientific research services in the field of the analysis and synthesis of proteins; quality control of peptides used in drug development; advice on quality control of peptides used in drug development; scientific research and development; scientific research and development in the field of immunization; generation, analysis and synthesis workflows for peptides
Where does the application stand?
| Date | Step on the record |
|---|---|
| 2026-10-06 | New application entered |
| 2026-10-06 | Application filing receipt mailed |
OMNITIDES is the only trademark application Crystal Bioscience, Inc. filed in the last 90 days, as far as the USPTO's daily records show.
MentionFox follows a brand's mentions across social platforms, news, forums and reviews. Sign up and OMNITIDES is already filled in as the brand to track.
Monitor mentions of OMNITIDESGetFoxChat puts an AI chat operator on your website that answers visitors from your own pages. Check your site to see what it would answer.
Check your site with GetFoxChatWho runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Crystal Bioscience, Inc.Where this comes from
A company that wants to protect a new brand name in the United States files a trademark application with the United States Patent and Trademark Office. The application names the mark, the company applying, the classes of goods and services it will be used for, in the company's own words, and whether the brand is already on sale or is still to launch. Each application gets a serial number and a public record that follows it through examination.
Every fact on this page is taken from that record and linked to it. MentionFox lists applications by companies only, corporations and limited liability companies; applications filed by individuals are not listed. A filing shows a company's plans for a name; it does not show sales, and an application can still be refused or abandoned.